Search

for
Search:

Sort by

Community Join

990-1000 / 1000+ results

community Veradermics VDPHL01 Topline Results for Extended-Release Oral Minoxidil

in Minoxidil 71 upvotes 3 months ago

Extended-release oral minoxidil (VDPHL01) shows promising results for hair growth with improved safety, achieving significant hair count increases and minimal side effects compared to placebo. The treatment is designed to maintain effective concentrations while reducing side effects, making it a safer option for those who cannot tolerate standard minoxidil.

community Will we ever hear about HMI -115

in Update 20 upvotes 3 years ago

Hair loss discussion includes treatments Minoxidil, Finasteride, and RU58841. Update on HMI-115 clinical trial expected in July or August.

community Just a suggestion for those suffering with itchiness along with MPB

6 upvotes 13 years ago

A user experienced severe scalp itching with MPB and found Nizoral ineffective. A doctor diagnosed seborrheic eczema and prescribed Betacap, which relieved the itching.

community Does anyone else feel that the hype for PP405 has gone?

in Chat 25 upvotes 3 months ago

The conversation discusses skepticism and diminishing excitement around the hair loss treatment PP405 due to unclear trial results. It also mentions other treatments like finasteride, minoxidil, VDPHL01 (extended-release minoxidil), and GT20026 as potential options for hair loss management.

community 21 y/o. MPB. Having an itchy/burning scalp no matter what I do or try. Any advice please? Thanks.

in Question 4 upvotes 6 years ago

A 21-year-old experiencing itchy and burning scalp with hair loss was diagnosed with MPB and scalp inflammation. They were prescribed Ketoconazole, Prednisone, Clindamycin, and Finasteride, and are considering trying antihistamines, dietary changes, and "nopoo" to alleviate symptoms.

community Am I crazy or is this recovery?

in Is this regrowth? 134 upvotes 1 year ago

The user is experiencing sudden hair loss and is considering micro-needling, low-level light therapy, iron supplements, folihair, and Omega 3. They are hesitant to start finasteride, suspecting the hair loss might be due to telogen effluvium from a past COVID-19 infection.

community Where are we with GT20029 ? Realistic Timeline ?

in Research/Science 9 upvotes 9 months ago

GT20029 is anticipated to start phase III trials in Q3 2026, with potential public availability around 2029-2030.

community Once daily topical Min, weekly 1.5 mm dermarolling

in Progress Pictures 35 upvotes 2 years ago

The user has been using 5% minoxidil once daily and microneedling with a 1.5 mm dermaroller weekly for three months, considering increasing minoxidil usage but avoiding finasteride due to libido concerns. Another person suggests considering other treatments like RU58841, alfatradiol, topical finasteride, clascoterone, or saw palmetto since not using a DHT blocker could be less effective.

community Breezula Phase III 12-Month Data Released by Cosmo Pharma

in Research/Science 39 upvotes 3 months ago

Clascoterone 5% topical solution is effective and safe for long-term use in treating male pattern hair loss. Cosmo Pharma aims for EU and US approval, with a potential US release in late 2027 or early 2028.

community MinoxidilMax just launched a 0.3% tretinoin topical. Would you try?

in Treatment 15 upvotes 4 years ago

The conversation discusses a new 0.3% tretinoin topical launched by MinoxidilMax for mixing with other solutions, with some users expressing concern about potential skin irritation compared to lower concentrations. MinoxidilMax has also released other products like topical Dutasteride and RU58841.

← Previous page